Meixin Institutional Food Development Co Ltd
Total Consideration
$4.3M
Purchase-Price Allocation
Intangibles
$3.9M
NOCERA, INC. — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
CCC is most informative for retail / industrial filers with material inventory. Service / software businesses naturally run near-zero CCC.
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$-0
Book Value Per Share
$-0
Free Cash Flow Per Share
$-0
Cash Per Share
$1
Revenue Per Share
$1
OCF Per Share
$-0
Return on Equity
-348.4%
Return on Assets
-44.2%
Return on Invested Capital
-17.3%
Debt to Equity
0.01
Current Ratio
12.06
Quick Ratio
12.06
Asset Turnover
2.09
Days Sales Outstanding
0.00
Days Payables Outstanding
0.00
Days Inventory On Hand
0.00
Cash Conversion Cycle
0.90
SBC / Revenue
0.4%
Capex / Revenue
0.0%
Working Capital
$8M
Net Current Asset Value
$352K
Invested Capital
$-441K
OCF / Net Income
0.90
FCF / Net Income
0.90
Accruals Ratio (Sloan)
-2.9%
Net Debt
$-8M
Net Debt / EBITDA
-37.77
Interest Coverage
—
Cash Coverage
—
Capex Coverage
-2192.00
Tangible Common Equity
$-441K
TCE / Total Assets
-4.4%
Goodwill / Total Assets
0.0%
NOPAT
$-772K
Cash ROIC
-312.7%
WC / Revenue
55.6%
Capex / D&A
0.01
Reinvestment Rate
11.4%
Asset Growth vs Revenue Growth
267.6%
Revenue 5Y CAGR
6.5%
Book Value 5Y CAGR
-3.9%
Stock Price (FY-end)
$1
Market Cap
$12M
P/S Ratio
0.89
P/B Ratio
5.35
P/TB Ratio
8.82
P/OCF Ratio
—
P/FCF Ratio
—
Enterprise Value
$4M
EV / EBITDA
19.92
EV / Sales
0.31
EV / FCF
—
FCF Yield
-21.3%
Shareholder Yield
-0.5%
Capex Yield
0.0%
Graham Number
—
Shares Variation (YoY)
8.0%
Beta (5Y)
0.30
Cost of Equity
6.0%
52W High
$2
52W Low
$1
Trailing Return 1Y
-1.7%
F-Score (Piotroski)
3.00
Z-Score (Altman)
11.87
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
Stock Price on Earnings Dates
NOCERA, INC. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | — | — | — | — | — | — |
| State & Local Income Taxes | — | — | — | — | — | — |
| Foreign Rate Differential | 2.90% | 0.00% | 1.07% | -0.01% | -0.04% | -0.02% |
| Other Adjustments | — | — | — | — | — | — |
| Nondeductible Expenses | -0.41% | 0.00% | -6.78% | -13.48% | -11.84% | -11.84% |
| Valuation Allowance Change | -21.19% | 18.73% | -1.01% | -0.49% | 0.00% | 0.00% |
| Effective Tax Rate | 6.36% | 6.27% | -1.43% | -0.01% | 0.00% | -6.10% |
Cash vs Accrual
| Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | −$90.0K | −$42.8K | $9.4K | −$23.8K | $22.7K | $234.6K |
| Income Taxes Paid (Cash) | $5.4K | — | — | — | — | — |
NOCERA, INC. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
Zhejiang Xinca Mutual Entertainment Culture Media Co Ltd
Total Consideration
$2.0M
Purchase-Price Allocation
Goodwill
$1.4M
Hangzhou SY Culture Media Co Ltd
Total Consideration
$642.0K
Purchase-Price Allocation
Goodwill
$230.0K